WellPrept Patient Education · Cancer Series

Understanding Testicular Cancer

A guide for men with a new diagnosis. Testicular cancer is one of the most curable cancers: about 95 in 100 men are cured overall, and 99 in 100 with early-stage disease. The treatment choices made in the first weeks shape sperm banking, nerve sparing, and long-term heart and hearing risk.

Version 1.0 · May 2026 Medically reviewed · Next review May 2027

Welcome

Most men with a new testicular cancer diagnosis are in their twenties or thirties, otherwise healthy, and came to the office expecting to hear that a lump was nothing. The next few weeks move quickly. Ultrasound, blood work, surgery, scans, and a treatment plan often happen inside a month.

About 95 out of 100 men with testicular cancer are cured, counting every stage together. Even when the cancer has already spread at diagnosis, cure is still the usual outcome. The chemotherapy behind that number was worked out in the late 1970s and refined for nearly fifty years since.

A high cure rate does not make this a small thing. The workup steps need to happen in the right order, and the choice between surveillance and more treatment has trade-offs. A man cured at 28 still has fifty years of life to protect, and the long-run effects of treatment drive the choices made today.

This guide pairs with the Cancer Basics guide, which covers the shared words and ideas across all cancers. Read that one first if you have not yet.

How to use this guide. The questions in Chapter 13 are written for your second visit; print them or copy them into your phone. The rest is here to look up when a question comes up at 10 p.m.

Chapter 01

Where you are now

It usually starts with a lump, then an ultrasound and a urology visit, and for some men surgery has already happened. From the first scan to a surgical plan often takes under two weeks.

The plain facts

Testicular cancer is uncommon. About 10,000 men in the United States are diagnosed each year. Your lifetime chance of being one of them is about 1 in 250. It hits younger men most, with the peak between ages 15 and 40 and a smaller second peak after 60.

It is also one of the most treatable cancers in adults. Across all stages, about 95 out of 100 men are cured. Even when the cancer has spread far at diagnosis, most men are cured by treatment.

~95%
Men cured across all stages of testicular cancer.
~99%
Cure rate for cancer caught before it has spread.
15-40
Age range when most cases are found.

What "cure" means here

Cure means the cancer is gone and stays gone. Most men reading this will get there. Cure does not mean unchanged. Some treatments have effects that show up in the years after. Your fertility may change. You may have one testicle instead of two. Some men carry long-run effects from chemotherapy or radiation.

The reaction is normal

Shock, anger, a flood of questions about fertility and partners and what your body will look like afterward, a sense of being moved along a process that started before you agreed to it. Those reactions show up at almost every new diagnosis visit. For most men they ease within a week or two, once there is a plan and the first appointments are scheduled.

!
A high cure rate still comes with choices

The choices in front of you affect the next fifty years. Ask your team about the long-term effects of each option, and expect answers even though the cancer is highly curable.

Chapter 02

How it gets found and diagnosed

Most men find the change themselves. The tests that follow tell your team what the lump is and whether the cancer has spread.

The first sign

The most common sign is a lump or swelling in the testicle. It is often painless. Some men feel a dull ache or heaviness in the scrotum. A smaller group has symptoms from spread first, like back pain, a new cough, or a lump in the neck above the collarbone.

Testicular self-exam

A monthly self-check in or after a warm shower helps you learn how your testicles normally feel. Roll each testicle gently between your thumb and fingers. You are feeling for a new lump, a hard spot, or a change in size. Most lumps men find are not cancer. Call your urologist or primary care doctor about any new finding.

What raises the risk

  • An undescended testicle at birth. Even if it was fixed by surgery as a child, the risk is higher.
  • A past testicular cancer. The other testicle has a 2 to 5 in 100 chance of getting a new cancer later.
  • A family member with it. Brothers and sons of men with testicular cancer have a higher risk.
  • Trouble with fertility or a low sperm count on past testing.
  • Klinefelter syndrome or HIV infection.

The workup, in order

  • Scrotal ultrasound. The first test. It tells the difference between a solid mass inside the testicle, which is likely cancer, and a harmless cause outside the testicle.
  • Tumor marker blood tests. Three blood tests called AFP, beta-hCG, and LDH. They are drawn before any surgery and again after. The pattern of these markers helps set your stage and your treatment plan.
  • Surgery to remove the testicle. This is the next step in almost every case. Doctors call it a radical inguinal orchiectomy. The cut is made in your groin rather than your scrotum, and the whole testicle and its cord are removed. A pathologist then examines the tissue, confirms the diagnosis, and tells the team what kind of cancer it is.
  • Staging scans. A CT scan of your chest, belly, and pelvis with contrast dye. This maps where else the cancer might be. An MRI of the brain is added if there is reason to think the cancer has reached the brain.
!
Do not let anyone biopsy through the scrotum

A needle or cut into the scrotum to sample a suspected testicular cancer is the wrong move. It can spread cancer cells to areas the body does not normally drain. The right approach is to remove the whole testicle through a groin cut. If anyone suggests a scrotal biopsy, ask for a second opinion before agreeing.

Chapter 03

Seminoma vs. NSGCT

The type on your pathology report sets most of the plan. Testicular germ cell cancer comes in two main types that behave differently and get treated differently.

Pure seminoma

About half of testicular germ cell cancers are pure seminoma. These tend to grow more slowly. They respond very well to both radiation and the main chemotherapy used for testicular cancer. The average patient is in his mid-thirties. Pure seminoma should not raise the AFP blood marker. If your AFP is up, your team will treat the cancer as the other type, no matter what the slides show.

Non-seminomatous germ cell tumor (NSGCT)

The other half are called NSGCT. The average patient is in his mid-twenties. These tumors tend to grow faster than seminoma and do not respond to radiation as well. They do respond very well to the same chemotherapy that works against seminoma. NSGCT is a family of subtypes. Most NSGCT cancers are mixed and contain more than one of these:

  • Embryonal carcinoma. The most aggressive of these types. It turns up in many mixed tumors.
  • Yolk sac tumor. Makes AFP.
  • Choriocarcinoma. Makes a lot of the marker beta-hCG. Rare on its own.
  • Teratoma. Made of mature or growing tissues. Does not respond to chemotherapy or radiation, so it has to be cut out.
  • Mixed. Two or more of the above in the same tumor.

Why this matters for you

The type drives the whole treatment plan, including:

  • Which markers your team will watch closely.
  • Whether radiation is an option at all.
  • How likely the cancer is to come back after stage I treatment.
  • What gets done with any leftover spots after chemo.

Other features on the report

Your pathology report may use the words lymphovascular invasion, often shortened to LVI. This means cancer cells were seen inside small vessels in the tumor. In stage I NSGCT, LVI is a sign of higher risk that the cancer will come back. It often changes what your team recommends after surgery.

i
Get a copy of your pathology report

Ask your office for a copy and bring it to your next visit. Find these three things: the type (seminoma or NSGCT), whether there is lymphovascular invasion, and the subtype mix if it is NSGCT. Your team will walk you through it.

Chapter 04

Stage, markers, and risk group

Once your team knows the type, two more things set the plan: where the cancer is, and how your blood markers behave.

The three tumor markers

  • AFP. Made by certain NSGCT cells. A normal level is expected in pure seminoma. A high level points to NSGCT.
  • Beta-hCG. Made by some seminomas and many NSGCTs. Very high in the type called choriocarcinoma.
  • LDH. A general marker that often tracks with how much cancer is in the body.

Markers are checked before surgery and again after. They fall on a known schedule when the cancer is gone. If they do not fall, or if they go up, the team takes that as a sign of cancer still in the body even when scans look clear.

The stages

  • Stage I. The cancer is in the testicle only. Scans are clear. Markers come back to normal after surgery.
  • Stage IS. Scans are clear but the markers do not fall. Treated as if the cancer has spread.
  • Stage II. The cancer has reached lymph nodes in the back of the belly, near the big blood vessels. Stage II is split into IIA, IIB, and IIC based on the size of those nodes.
  • Stage III. The cancer has reached organs farther away, most often the lungs. Or nodes above the diaphragm. Or the markers are very high.

Five-year survival by stage

These are the five-year survival numbers for germ cell tumors of the testicle. Stage I is about 99 out of 100. Stage II is about 92 out of 100. Stage III is about 85 out of 100. Counting every stage together, the number is about 95 out of 100.

The IGCCCG risk group

For men with cancer that has spread, doctors use a risk score called IGCCCG. It uses your marker levels and where the spread is to sort you into a group. The group predicts how likely cure is and sets how many cycles of chemotherapy you get.

Risk group is a separate thing from stage. The survival numbers in the three tiles below go with the risk group, not with the stage.

Good risk
5-yr ~92-95%
No spread outside lung. Markers in a lower range. Most patients land here.
Intermediate risk
5-yr ~80-85%
Markers higher but not extreme. Or NSGCT with mid-range marker levels.
Poor risk
5-yr ~67-75%
Spread to liver, brain, or bone. Or very high markers. NSGCT only.

Seminoma has only two risk groups, good and intermediate.

Putting it together

By the end of this part of the workup, you and your team will know three things: your type (seminoma or NSGCT), your stage (I, II, or III), and, if it has spread, your IGCCCG risk group. Those three answers drive every treatment choice that follows.

Chapter 05

Bank sperm before any treatment

The window to bank sperm closes fast once treatment starts, and the effects of missing it can last the rest of your life.

!
Bank sperm before any treatment

Before the orchiectomy if scheduling allows. Always before chemotherapy or RPLND. Bring it up at your first urology visit if no one else has. If your team waves it off, that is the moment to ask again, in writing if you need to.

Why this matters so much

About half of men with a new testicular cancer already have a below-normal sperm count at diagnosis, before any treatment touches them. Most men with one healthy remaining testicle stay fertile, but somewhere around 1 in 5 do not. Cisplatin-based chemotherapy can drop sperm counts to zero for months to years. In some men the count never comes back. RPLND surgery in the back of the belly can damage the nerves that push semen forward at ejaculation, in which case conceiving without help becomes very difficult. A sample frozen before treatment starts protects you in all of these situations.

How banking actually works

  • Time. One to three samples, produced at a sperm bank over a day or two. A 48-hour window before your next step is almost always feasible.
  • Where. Most cities have a sperm bank, and your urology or oncology office can usually call ahead and book you in. A handful of practices have one on site.
  • Cost. Roughly $500 to $1,000 to collect and freeze, then $300 to $500 a year to store. That is a small cost against decades of potential use.
  • Insurance. A growing number of plans pay for fertility preservation in cancer patients, but plenty still do not. If yours does not, ask the social worker about Livestrong Fertility, the Chick Mission, and similar foundation programs.

The four reasons men give for skipping

  • "I am not thinking about kids right now." The decision is for the man you will be in ten or twenty years. Banking keeps the option open, and you can decide later whether to use it. Once treatment has changed your sperm, there is no going back to bank an earlier sample.
  • "No one has brought it up yet." Oncology guidelines call for every patient to be offered fertility preservation. Raise it yourself if it has not come up, and do it before the first chemo cycle is on the calendar.
  • "There is no time." A 24 to 48-hour pause before chemotherapy is almost always safe in testicular cancer, even in poor-risk disease. If your oncologist tells you there is no window, ask what specifically about your case rules it out.
  • "Cost." If cost is a barrier, tell your team early. The social worker at your cancer center can name the grants and discount programs that cover this.

If you have a partner

Bring your partner into the conversation early. Couples often find the fertility decision easier to discuss than the cancer itself, because the action is concrete and the timeline is short.

If you have already started treatment

Banking between cycles is still recommended. The sample quality is lower than a pre-treatment sample. If a post-treatment sample shows no sperm at all, a procedure called microTESE pulls sperm directly from a small piece of testicle tissue under the operating microscope. It works in a meaningful number of men who appear sterile on a regular sample. Any fellowship-trained male-fertility urologist can do it.

Chapter 06

Treatment, stage by stage

Surgery to remove the testicle is the first treatment in nearly every case. What comes next depends on the type, the stage, and the risk group.

Stage I seminoma

About 80 out of 100 seminoma cases are caught at stage I. Cure rates are about 99 out of 100 men with any of the choices below.

  • Surveillance (most common today). No more treatment after surgery. Close follow-up with scans and blood work for several years. The cancer comes back in about 12 to 20 out of 100 men, almost always in the back of the belly, and almost always cured by treatment at that point.
  • One dose of a chemotherapy called carboplatin. Lowers the chance of return to about 4 to 5 out of 100. Some short-term side effects. An option for men who cannot keep up with years of follow-up scans.
  • Radiation to the belly nodes. Used much less often now, because of concerns about second cancers and heart disease many years out.

Stage I NSGCT

About 70 out of 100 NSGCT cases are caught at stage I. Cure rates are about 99 out of 100 men with any of the choices below.

  • Surveillance. Often the first choice. The cancer comes back in about 25 to 30 out of 100 men overall, more in men with lymphovascular invasion, less without. Most relapses are cured by chemotherapy.
  • One cycle of BEP chemotherapy. Drops the chance of return to about 1 to 3 out of 100. Often offered if there is lymphovascular invasion on the pathology report.
  • RPLND surgery (see next chapter). Used in some cases, often when the tumor has a lot of embryonal carcinoma or likely teratoma in it.

Stage II and III: BEP chemotherapy

For cancer that has spread, the main treatment is a chemotherapy regimen called BEP. It uses three drugs: bleomycin, etoposide, and cisplatin. The number of cycles depends on your IGCCCG risk group.

  • Good risk: 3 cycles of BEP, given over about 9 weeks. Cure rate about 90 to 95 out of 100.
  • Intermediate risk: 4 cycles of BEP, over about 12 weeks. Cure rate about 80 to 85 out of 100.
  • Poor risk (NSGCT only): 4 cycles of BEP. Cure rate about 67 to 75 out of 100. High-volume cancer centers have other options including high-dose chemotherapy with stem cell support.

For stage IIA seminoma (small nodes in the back of the belly), radiation or a short course of BEP are both used. For stage IIB and beyond, BEP is taking over as the more common choice.

If the cancer comes back

Relapse after first-line treatment happens to a minority of men, and there is a second line of treatment if it does. Salvage chemotherapy regimens called TIP and VeIP cure roughly half of patients who relapse after BEP. High-dose chemotherapy followed by stem cell rescue, done at centers with deep experience, raises that further in selected cases. Cure rates are lower than the first time around. Ask for an early second opinion at a high-volume program if relapse is on the table.

+
Ask about a high-volume center

Testicular cancer is rare. Skill comes from doing a lot of it. Ask about a second opinion at a center that sees many cases each year, above all for stage II or III, for RPLND surgery, or for any odd pathology. Your local team can help set it up.

Chapter 07

Surgery: orchiectomy and RPLND

There are two main surgeries in testicular cancer care. The first removes the testicle. The second, used in selected cases, clears lymph nodes deep in the back of the belly.

Orchiectomy: removing the testicle

This is the first treatment in almost every case. Through a cut in your groin on the side of the cancer, the surgeon removes the whole testicle and the cord it sits on, then sews up the layers. The other testicle is left in place.

  • The setting. Same-day for most men. You will be asleep or numb from the waist down.
  • Recovery. Most men go home that day. A few days of soreness. Most are back to office work in a week and to harder activity by 2 to 4 weeks.
  • What changes after. Most men with one healthy other testicle have normal levels of testosterone and normal erections. Most stay fertile. A minority do not. About 1 in 5 to 1 in 4 men develop low testosterone over the years and may need replacement.

About the prosthesis

A silicone testicular prosthesis can be placed in the empty side of the scrotum, either during the orchiectomy itself or as a separate procedure months or years later. It is entirely your choice, and there is no medical reason to have one or to skip it. Most insurance plans cover the device and the placement. You can decide either way now and change your mind later.

RPLND: clearing the back-of-the-belly nodes

RPLND stands for retroperitoneal lymph node dissection. This is a much larger operation. The surgeon removes the lymph nodes that drain the testicle. They sit deep in the belly, near the big blood vessels.

RPLND is used in two settings:

  • Primary RPLND. Used in some stage I NSGCT cases. It is most useful when the tumor has a lot of embryonal carcinoma, or likely teratoma (a type that resists chemo).
  • Post-chemotherapy RPLND. Used when a spot is left after BEP chemo in NSGCT, bigger than about 1 centimeter. About 40 out of 100 of these spots are teratoma, which has to come out. About 40 are just scar tissue. The rest are still cancer and need more care.

Many centers now do parts of this surgery with a robot or with small cuts. Open surgery is still used, above all after chemo. Open RPLND takes 4 to 6 weeks to bounce back from.

The ejaculation point

Nerves that drive forward ejaculation run near the big blood vessels in the back of the belly. RPLND can damage them. Surgeons trained in this operation use a "nerve-sparing" approach when possible. In selected primary RPLND cases, more than 9 in 10 men keep forward ejaculation. Rates are lower after chemotherapy RPLND because the surgery is more extensive.

If forward ejaculation is lost, you still have an orgasm, but no fluid comes out the front. Some men have what is called retrograde ejaculation, where the fluid goes into the bladder. Conceiving a child without help becomes very hard. This is one more reason banked sperm matters.

i
Where the surgeon does the operation matters

RPLND is technical. Outcomes are better at centers that do many of them. If your local team recommends RPLND, ask how many they do each year and whether a second opinion at a high-volume center is reasonable. A good surgeon welcomes this question.

Chapter 08

Living through treatment

Most men who are treated for testicular cancer have decades of life ahead. The way you live during and after treatment shapes those decades.

The pace of BEP

BEP chemotherapy runs about 9 to 12 weeks. You will be in the infusion chair on a week-on, week-off pattern within each cycle. Side effects layer on: tiredness, nausea, hair loss, mouth sores, low blood counts. Most men can keep some normal life going, but the cycle takes over a lot of the calendar.

Body image and one testicle

Most men have never had to think about the scrotum. Losing half of what is in there is often harder than the size of the operation suggests. A prosthesis can be placed at the time of surgery or years later, as covered in Chapter 7. If how you feel about your body is affecting your mood, your sleep, or your relationships, bring it up at a follow-up visit.

Dating and partners

The question of how and when to tell a new partner comes up in almost every clinic visit with a younger patient. Partners tend to care much less than men expect, and many do not notice on their own. A sentence or two somewhere in the first few dates usually goes fine. Most men find that easier than holding it back until it becomes a bigger conversation a month later.

Mental health

Scanxiety is the word for the dread that builds in the week before a follow-up scan. Most people get it. Booking the scan and the follow-up call within 48 hours of each other shortens the wait, and scheduling the appointment early in the week keeps a result from sitting unread over a weekend. If the anxiety is interfering with sleep, work, or your relationships, two or three sessions with a therapist who works with cancer patients usually helps. Short courses of medication are also reasonable; your oncology team can refer you or your primary care doctor can prescribe.

Money and work

Time away from work, copays for chemotherapy, follow-up scans, and travel can add up. Your cancer center has a social worker, and many drug companies and foundations have copay help. The Family and Medical Leave Act protects time off in many jobs. Ask early, because most help is easier to get before the bills pile up.

Survivor community

The Testicular Cancer Foundation and Movember run two of the largest survivor groups. Many men find that talking with someone who has been through the same treatment helps more than anything they read online.

+
Palliative care is for any stage

Many patients hear the word palliative and think hospice. Palliative care is symptom-management care that runs alongside curative treatment. The team handles nausea that is not responding, pain, sleep, mood, and the family conversations that are hard to start. Ask your oncologist for a referral any time a side effect is wearing you down.

Chapter 09

Side effects, side by side

Every active treatment for testicular cancer has trade-offs in the short term, in fertility, and in the long run.

ChoiceShort-termFertilityLong-term
Orchiectomy alone2 to 4 weeks of recovery. Soreness in the groin and scrotum.Most men stay fertile with one healthy testicle. A minority do not.About 1 in 5 to 1 in 4 men develop low testosterone over time. Prosthesis is optional.
Surveillance (stage I)None.Unchanged.Years of scans and visits. Radiation dose from CT scans. Worry around scan time.
Carboplatin, one doseTiredness, low counts for 1 to 3 weeks.Small effect.Generally mild long-term profile.
Radiation to belly nodesTiredness, mild nausea, loose stools for 2 to 3 weeks.Some scatter to the other testicle. Shielding helps.Higher lifetime chance of stomach, pancreas, and bladder cancer many years later. Higher risk of heart disease.
BEP chemotherapy9 to 12 weeks. Nausea, tiredness, hair loss, low counts, mouth sores.Low or zero sperm count for months to years. Some men recover. A minority do not.Heart disease, neuropathy, hearing loss, ringing in the ears, kidney effects, low testosterone, small risk of lung scarring from bleomycin, small risk of secondary leukemia.
Primary RPLND (nerve-sparing)4 to 6 weeks of recovery. Belly pain, slowed bowel function.Forward ejaculation kept in more than 9 of 10 selected cases. Loss means dry orgasm.Hernia risk at the cut. Rare bowel blockage.
Post-chemo RPLNDLarger surgery, longer recovery, more complications.Higher chance of losing forward ejaculation than primary RPLND.Stacks with the long-term effects of the chemotherapy that came first.

Erections and sex drive

Taking out one testicle on its own does not change erections for most men. Erection trouble after care more often comes from low testosterone, blood vessel changes from chemo, normal aging, or stress. Most of these can be treated if you bring them up at a visit.

Testicular cancer is one of the most curable cancers in adults. About 95 out of 100 men are cured across all stages, and 99 out of 100 when it is caught before it spreads. Some side effects (low testosterone, heart and kidney changes, second cancers) can show up 15 to 20 years later, which is why long-term follow-up is part of the care.
Chapter 10

Surveillance and when to call

Follow-up for testicular cancer runs for years, with a set schedule of visits and scans and a short list of symptoms that should prompt a call in between.

What follow-up looks like

The exact schedule depends on your stage and type. The pattern below is a rough guide. Your team will write yours down.

  • Stage I seminoma on surveillance: markers and visits every 3 to 6 months for the first 2 years, with CT scans every 6 to 12 months. The pace stretches out over 5 to 10 years.
  • Stage I NSGCT on surveillance: markers and chest imaging every 2 months in year 1, with CT scans every 3 to 4 months. The pace stretches out over the next several years.
  • After chemo or RPLND: closer follow-up in the first 2 years. Then it spreads out.
  • After 10 years: check-ins with your regular doctor. Self-exam of the other testicle for life.

Why the schedule matters

Most relapses happen in the first 2 to 3 years, and almost all are cured by treatment given at that point. Put the dates on a calendar and set reminders. Telling a partner or family member when they are coming up helps too.

!
Call your team the same day during chemo or just after

A fever, especially over 100.4°F. New shortness of breath, cough, or chest pain. Severe nausea or vomiting that keeps you from drinking fluids. Severe belly or back pain. Calf swelling or pain (clot in a leg vein). New numbness, weakness, or trouble walking.

After treatment, call any time for

  • A new lump in your other testicle.
  • Steady new back pain that is not going away.
  • New cough or shortness of breath that lasts more than a few days.
  • Blood in your urine.
  • A sudden bad headache or new neurologic change.

Surveillance fatigue sets in

Almost every patient is rigorous about the first year of scans. By year three or four, when life has moved on, the appointments start to feel optional. Late heart and second-cancer effects keep developing over that time, and recurrences in years four and five, while uncommon, still happen and still need to be found. A 30-minute visit once a year through your forties and fifties is what catches those things early.

Chapter 11

The long tail of cure

Because cure rates are so high and most men are young, testicular cancer care runs over many decades. The late effects below are the ones your care team watches for.

Heart and blood vessel disease

Men who got the chemo drug cisplatin have a higher chance of heart attack, stroke, high blood pressure, high cholesterol, and metabolic syndrome (a cluster of weight and blood sugar issues) years later. The risk shows up 10 to 30 years out. Not smoking and staying active matter more for you than for the average man your age. So does keeping your blood pressure and your weight in a healthy range.

Second cancers

Care for testicular cancer adds a small lifetime risk of other cancers. Radiation can raise the risk of stomach, pancreas, and bladder cancer 15 to 30 years out. The chemo drug etoposide carries a small risk (less than 1 in 100) of a blood cancer called leukemia. The other testicle has a 2 to 5 in 100 lifetime chance of a new cancer.

Low testosterone

Up to 1 in 4 men develop low testosterone over the years. The signs are low energy, low sex drive, weight gain, mood changes, and trouble with erections. Many men chalk it up to aging. Ask for a testosterone blood test at any follow-up visit. Replacement is available if you need it.

Nerve, hearing, and lung effects of chemotherapy

  • Numbness or tingling in feet and hands. Common after cisplatin. Often slow to improve. Sometimes permanent.
  • Hearing loss and ringing in the ears. Cisplatin is harder on the ears. A baseline hearing test before chemotherapy and another after can document any change. Wear ear protection in loud places for the rest of your life.
  • Lung scarring from bleomycin. Not common. Serious when it happens. The risk is higher in smokers, older men, and after high doses of oxygen in surgery. Tell any future surgeon or anesthesia doctor if you ever had bleomycin.
  • Cold-finger changes. Some men get color shifts in fingers and toes in the cold after chemo. Most of the time it is mild.
  • Kidney effects. Slightly lower kidney function over time in many men. Most never notice.

Fertility and family-building

Most men recover sperm count after BEP, over months to a few years. A meaningful minority do not. Banked sperm covers you either way. If you have no sperm in a sample post-treatment, a specialized procedure called microTESE can sometimes find sperm directly from the testicle. Many men in this situation go on to have children.

Tell your primary care doctor about all of this

Long after your cancer care wraps up, your primary care doctor is the person who watches your heart risk, your blood pressure, your cholesterol, your blood sugar, and your testosterone. Bring a one-page summary of your cancer treatment to every new doctor. Your cancer center can give you one, called a survivorship care plan.

+
Why baselines are set before chemotherapy

A 25-year-old cured of testicular cancer has another fifty years ahead. That is why care teams set baselines for hearing, lungs, and testosterone before chemotherapy starts, and why a one-page survivorship plan in your primary care chart matters as much at age 45 as the original treatment did at 25.

Chapter 12

Genes, family, the other testicle

Testicular cancer runs in some families. It does not work like a few other cancers, where a single gene change carries a large risk.

Family risk, in plain terms

If you have a brother with testicular cancer, your lifetime risk is several times higher than the average man's. In plain numbers, that means going from about 4 out of 1,000 to about 20 to 30 out of 1,000. If your father had it, the bump is smaller but still there. Scientists have found many small gene differences that contribute. There is no single high-risk gene like there is in some other cancers.

Genetic testing

Most men with testicular cancer do not need gene testing. It can make sense if a few close relatives have had testicular cancer, or if your family has an unusual cancer pattern. A genetic counselor can tell you whether testing would help in your case and what it would show.

Tumor testing

Most testicular germ cell cancers carry extra 12p material (an extra piece of a chromosome). Pathologists sometimes look for it when a cancer is hard to identify, to confirm it started in a testicle. Most cases do not need deeper molecular testing, because the standard chemotherapy works so well.

The other testicle

You have a 2 to 5 out of 100 lifetime chance of a new cancer in your other testicle. That is why a monthly self-exam stays part of your routine for life. Roll the testicle gently in the shower and feel for a new lump or change. If you find something, an ultrasound is the next step. Most lumps men find are not cancer, and self-exam is how most of the ones that are get caught early.

Your sons and brothers

Your brothers have a higher chance than the average man and should know about it. Monthly self-exam after puberty is the recommendation for them. If you have a son with an undescended testicle, that should be fixed by a children's urologist, usually before age 2. Fixing it does not erase the higher cancer risk, but it lets a doctor and you watch the testicle as he grows.

i
A short talk with your brothers

Most men never mention their diagnosis to their brothers. A two-minute version of how yours was found, plus a nudge to do a monthly self-exam in the shower, is enough. Cases get caught every year because a brother had been through it first.

Chapter 13

Questions to ask your team

Bring this page to your next visit. The right questions are hard to think of on the spot.

About my cancer

  • Is my tumor pure seminoma or NSGCT? If NSGCT, what subtypes are in the mix?
  • Does the path report show LVI (cancer cells in small vessels)?
  • What is my stage? If it has spread, what is my IGCCCG risk group?
  • Where exactly has it spread, if anywhere?

Before any treatment

  • Can I bank sperm before treatment starts? Where? How fast?
  • What did my markers do after surgery? Are they on the right path?
  • Has my case been seen at a tumor board (a group review)?
  • Is a second opinion at a high-volume testicular cancer center a good idea?

About the plan

  • What are my options? What do you recommend, and why?
  • If I choose surveillance, what is the schedule, and for how long?
  • If I am getting BEP, how many cycles, and what are the side effects to watch for?
  • If RPLND is on the table, how many do you do each year? Would a higher-volume center do it differently?

About side effects and life

  • What baseline tests do I need before BEP (hearing, lung, kidney, testosterone)?
  • Should I think about a testicular prosthesis now or later?
  • Can I see a palliative care team alongside my main treatment?
  • Who do I call after hours if something feels wrong?

About the years after

  • What is my follow-up schedule for the next 5 to 10 years?
  • What late effects should I watch for, and when?
  • What survivorship care plan can I get to bring to my primary care doctor?
  • Are there survivor or peer-support groups you recommend?
Chapter 14

Words to know

General cancer words live in the Cancer Basics guide. These are the ones used most in testicular cancer care.

Germ cell tumor
A cancer that starts from sperm-making cells. Most testicular cancers are this kind.
Seminoma
One main type of testicular cancer. Slower growing. Responds well to radiation and chemotherapy.
NSGCT
Non-seminomatous germ cell tumor. The other main type. Faster growing. Treated with chemotherapy and surgery.
Embryonal carcinoma
The most aggressive piece of NSGCT.
Yolk sac tumor
An NSGCT type that makes the AFP marker.
Choriocarcinoma
A rare NSGCT type that makes high beta-hCG and can bleed.
Teratoma
A germ cell tumor type that does not respond to chemotherapy or radiation. Has to be cut out.
Mixed germ cell tumor
An NSGCT that contains two or more subtypes.
AFP
Alpha-fetoprotein. A blood marker. High in many NSGCTs. Normal in pure seminoma.
Beta-hCG
A blood marker. Highest in choriocarcinoma. Sometimes high in seminoma.
LDH
A general blood marker that often goes up with the amount of cancer in the body.
Radical inguinal orchiectomy
Surgery to remove the testicle through a groin cut. The standard first treatment.
Trans-scrotal biopsy
A needle or cut into the scrotum to sample a testicle mass. The wrong move in testicular cancer.
Testicular prosthesis
A silicone implant placed in the scrotum after the testicle is removed. Optional.
IGCCCG
The risk-group system used worldwide for testicular cancer that has spread.
Stage IS
Clear scans but tumor markers that do not drop. Treated as if the cancer has spread.
BEP
The main chemotherapy regimen: bleomycin, etoposide, and cisplatin.
EP
Etoposide and cisplatin only, used when bleomycin is not safe.
RPLND
Retroperitoneal lymph node dissection. Surgery to clear the back-of-the-belly nodes that drain the testicle.
Nerve-sparing RPLND
A version of RPLND that tries to save the nerves that drive forward ejaculation.
Antegrade ejaculation
Forward ejaculation through the urethra. The normal pattern.
Retrograde ejaculation
Ejaculation that goes backward into the bladder. Can happen after RPLND.
Lymphovascular invasion (LVI)
Cancer cells found inside small blood or lymph vessels in the tumor. A risk feature.
Sperm banking
Freezing a sperm sample for later use. Do this before treatment.
microTESE
A small surgery to find sperm directly in the testicle when no sperm appear in a sample.
Low testosterone (hypogonadism)
Low levels of the main male hormone. Common over time after testicular cancer.
Bleomycin lung toxicity
Scarring of the lungs from bleomycin. Tell future anesthesia teams you had this drug.
Scanxiety
The worry that builds before each follow-up scan. Very common.
Survivorship care plan
A summary of your cancer treatment to share with your primary care team for life.
Cryptorchidism
An undescended testicle. A childhood condition that raises lifetime testicular cancer risk.
Sources

Sources and further reading

This guide draws on current society guidelines and the major studies behind today's standard of care. The list below points to where you can read more.

  1. NCCN Testicular Cancer Guidelines. nccn.org
  2. NCCN Patient Guidelines: Testicular Cancer. nccn.org/patients
  3. EAU Testicular Cancer Guidelines. uroweb.org
  4. IGCCCG Update 2021. ascopubs.org
  5. Original IGCCCG 1997. ascopubs.org
  6. ASCO Fertility Preservation Guideline. ascopubs.org
  7. NCI Testicular Cancer Treatment. cancer.gov
  8. American Cancer Society: Testicular Cancer. cancer.org
  9. Testicular Cancer Foundation. testicularcancer.org
  10. Platinum Study (Indiana University long-term survivorship). platinumstudy.org
  11. Movember (men's health and survivor community). movember.com
  12. Get Palliative Care: What is palliative care? getpalliativecare.org
  13. ClinicalTrials.gov. clinicaltrials.gov
  14. National Society of Genetic Counselors (find a counselor). nsgc.org

About this guide. The numbers and choices here describe testicular cancer in general. Your own case will sit somewhere inside those ranges. Use this guide to prepare questions for your oncology and urology team; it does not replace their advice.

Playing audio...